×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: novavax shares jump | covid vaccine | fda

Novavax Shares Jump as FDA Panel Backs COVID Vaccine

Novavax Shares Jump as FDA Panel Backs COVID Vaccine
(AP)

Wednesday, 08 June 2022 07:24 AM EDT

Shares of Novavax Inc. surged nearly 20% on Wednesday after advisers to the Food and Drug Administration overwhelmingly backed the use of its COVID-19 vaccine, bringing the shot a step closer to a U.S. launch.

The stock tumbled about 20% on Friday after the heath regulator's reviewers flagged concerns of a type of heart inflammation following the vaccination, adding uncertainty over the outcome of Tuesday's meeting.

However, the voting by the outside advisers —21 for, none against and 1 abstention — indicates that the FDA could soon authorize the fourth vaccine in the United States, where Novavax hopes it would become the shot of choice among vaccine skeptics.

The positive vote "acknowledges the strength of our data and the importance of a protein-based Covid-19 vaccine," Novavax Chief Executive Officer Stanley Erck said Tuesday.

The FDA panel voting is a positive development for Novavax, analysts said, as it reduces uncertainty around a vaccine that has had a long path to authorization.

Jefferies analyst Roger Song said the cases of a type of heart inflammation, though concerning, would result in a warning very similar to that of rival mRNA vaccines from Moderna Inc and Pfizer.

The vote marks a "challenge to the dominance of mRNA vaccines in the COVID-19 market," said SVB Securities analyst Mani Foroohar in a note.

If the FDA authorizes the vaccine, the U.S. Centers for Disease Control and Prevention will need to endorse it before becoming available in the country.

Novavax's shares were up 19% at $56.59 before the bell.

© 2022 Thomson/Reuters. All rights reserved.


StreetTalk
Shares of Novavax Inc. surged nearly 20% on Wednesday after advisers to the Food and Drug Administration overwhelmingly backed the use of its COVID-19 vaccine, bringing the shot a step closer to a U.S. launch.
novavax shares jump, covid vaccine, fda
251
2022-24-08
Wednesday, 08 June 2022 07:24 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved